[go: up one dir, main page]

WO2009020577A3 - Innovative formulation for oral insulin delivery - Google Patents

Innovative formulation for oral insulin delivery Download PDF

Info

Publication number
WO2009020577A3
WO2009020577A3 PCT/US2008/009365 US2008009365W WO2009020577A3 WO 2009020577 A3 WO2009020577 A3 WO 2009020577A3 US 2008009365 W US2008009365 W US 2008009365W WO 2009020577 A3 WO2009020577 A3 WO 2009020577A3
Authority
WO
WIPO (PCT)
Prior art keywords
insulin delivery
oral insulin
innovative formulation
formulation
innovative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/009365
Other languages
French (fr)
Other versions
WO2009020577A2 (en
Inventor
Allan E David
Arthur J Yang
Yoon Jeong Park
Li-Chien Chang
Victor C Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industrial Science and Technology Network Inc
Original Assignee
Industrial Science and Technology Network Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industrial Science and Technology Network Inc filed Critical Industrial Science and Technology Network Inc
Publication of WO2009020577A2 publication Critical patent/WO2009020577A2/en
Publication of WO2009020577A3 publication Critical patent/WO2009020577A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides for an encapsulated, mucoadhesive oral formulation for hormones, such as insulin, and methods of using such formulations.
PCT/US2008/009365 2007-08-03 2008-08-04 Innovative formulation for oral insulin delivery Ceased WO2009020577A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93529207P 2007-08-03 2007-08-03
US60/935,292 2007-08-03

Publications (2)

Publication Number Publication Date
WO2009020577A2 WO2009020577A2 (en) 2009-02-12
WO2009020577A3 true WO2009020577A3 (en) 2009-05-28

Family

ID=40341942

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/009365 Ceased WO2009020577A2 (en) 2007-08-03 2008-08-04 Innovative formulation for oral insulin delivery

Country Status (1)

Country Link
WO (1) WO2009020577A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3010524B1 (en) * 2013-06-18 2019-12-25 University of Helsinki Protamine in treatment of neuronal injuries

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5442043A (en) * 1992-11-27 1995-08-15 Takeda Chemical Industries, Ltd. Peptide conjugate
WO2004081188A2 (en) * 2003-03-10 2004-09-23 The Regents Of The University Of Michigan Non-toxic membrane-translocating peptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5442043A (en) * 1992-11-27 1995-08-15 Takeda Chemical Industries, Ltd. Peptide conjugate
WO2004081188A2 (en) * 2003-03-10 2004-09-23 The Regents Of The University Of Michigan Non-toxic membrane-translocating peptides

Also Published As

Publication number Publication date
WO2009020577A2 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
WO2007121318A3 (en) Formulations for delivering insulin
WO2009086400A3 (en) Recombinant vwf formulations
IL192967A0 (en) Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
WO2010048275A3 (en) Lyophilized recombinant vwf formulations
WO2009046444A3 (en) Formulation for intranasal administration of diazepam
WO2008057550A3 (en) Stabilization of vaccines by lyophilization
WO2010021607A3 (en) Pharmaceutical formulation
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2008121767A3 (en) Stitched polypeptides
WO2012076293A9 (en) Formulations comprising polysiloxanes having nitrogen-containing groups
PL2081547T3 (en) Galenic form for the trans-mucosal delivery of active ingredients
WO2009121039A3 (en) Administration of benzodiazepine compositions
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
WO2007117556A3 (en) Pharmaceutical compositions and uses thereof
WO2009014855A3 (en) Ink formulations and methods of making ink formulations
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
PL2079446T3 (en) Paliperidone sustained release formulation
WO2006131591A3 (en) An entacapone-containing oral dosage form
WO2004087100A3 (en) Cladribine formulations for improved oral and transmucosal delivery
WO2008046865A3 (en) Long-term feed - elderly
WO2009120380A3 (en) Recombinant rhinovirus vectors
WO2010046061A3 (en) Cosmetic and/or pharmaceutical formulations
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
WO2007133944A3 (en) Topical administration of acyclovir
MX2009012370A (en) Low-viscous anthracycline formulation.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08780353

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08780353

Country of ref document: EP

Kind code of ref document: A2